SQUAMOUS CELL CARCINOMA OF THE OROPHARYNX
Clinical trials for SQUAMOUS CELL CARCINOMA OF THE OROPHARYNX explained in plain language.
Never miss a new study
Get alerted when new SQUAMOUS CELL CARCINOMA OF THE OROPHARYNX trials appear
Sign up with your email to follow new studies for SQUAMOUS CELL CARCINOMA OF THE OROPHARYNX, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New lozenges aim to shrink tumors before cancer surgery
Disease control OngoingThis study is testing if a new lozenge called APG-157 can safely shrink head and neck tumors before patients start their main cancer treatment, like surgery or radiation. Researchers want to see if reducing the tumor size first leads to better outcomes. The study involves 24 newl…
Matched conditions: SQUAMOUS CELL CARCINOMA OF THE OROPHARYNX
Phase: PHASE2 • Sponsor: Aveta Biomics, Inc. • Aim: Disease control
Last updated Mar 31, 2026 12:12 UTC
-
New surgical technique aims to unmask hidden cancers
Diagnosis OngoingThis study aims to improve the detection of the hidden original site of head and neck cancer that has already spread to lymph nodes. It tests a surgical procedure to remove tissue from the back of the tongue, followed by a detailed lab analysis method, to find these hidden cancer…
Matched conditions: SQUAMOUS CELL CARCINOMA OF THE OROPHARYNX
Sponsor: Royal Marsden NHS Foundation Trust • Aim: Diagnosis
Last updated Mar 25, 2026 14:08 UTC